Dendritic cell-based therapeutics for breast cancer
/in Breast Cancer, Dendritic Cells, International Publications /von 2004-01-01 / Breast Dis 2004;20:65-71The immune response to breast cancer, and the case for DC immunotherapy
/in Breast Cancer, Dendritic Cells, International Publications /von 2004-01-01 / Cytotherapy 2004;6(2):154-63DC-based immunotherapy of B-cell malignancies
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2004-01-01 / Cytotherapy 2004;6(1):62-7Dendritic cell-based immunotherapy in multiple myeloma
/in Dendritic Cells, International Publications, Malignant Lymphoma, Multiple Myeloma /von 2003-12-01 / Leuk. Lymphoma 2003 Dec;44(12):2031-8Dendritic cell-based combined immunotherapy with autologous tumor-pulsed dendritic cell vaccine and activated T cells for cancer patients: rationale, current progress, and perspectives
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2003-12-01 / Hum. Cell 2003 Dec;16(4):175-82Intranodal administration of peptide-pulsed mature dendritic cell vaccines results in superior CD8+ T-cell function in melanoma patients
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2003-10-15 / J. Clin. Oncol. 2003 Oct;21(20):3826-35Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial
/in Dendritic Cells, Glioblastoma, International Publications /von 2003-10-06 / Br. J. Cancer 2003 Oct;89(7):1172-9Idiotype vaccination of multiple myeloma patients using monocyte-derived dendritic cells
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2003-10-01 / Haematologica 2003 Oct;88(10):1139-49Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells
/in Breast Cancer, Dendritic Cells, International Publications /von 2003-10-01 / Clin. Cancer Res. 2003 Oct;9(12):4376-86IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de